|
FY2025
12 months to Sep 30, 2025
|
|
|---|---|
| General and administrative | |
| Research and development | |
| Sales and marketing | |
| Total operating expenses | |
| Loss from operations | |
| Interest income | |
| Interest expense | |
| Change in fair value of convertible notes payable | |
| Gain from sale of marketable securities | |
| Total other (expense) income, net | |
| Loss before provision for income taxes | |
| Net loss | |
| Basic and diluted weighted average shares outstanding | |
| Basic and diluted net loss per share |
Loading...
